Agenus Net Income from 2010 to 2026

AGEN Stock  USD 3.06  0.15  4.67%   
Agenus Net Loss yearly trend continues to be very stable with very little volatility. Net Loss is likely to grow to about -194.3 M this year. During the period from 2010 to 2026, Agenus Net Loss quarterly data regression pattern had range of 234.4 M and standard deviation of  83,426,577. View All Fundamentals
 
Net Loss  
First Reported
2000-03-31
Previous Quarter
-28 M
Current Value
63.9 M
Quarterly Volatility
29.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Agenus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agenus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 16.1 M, Interest Expense of 142 M or Selling General Administrative of 86.8 M, as well as many indicators such as Price To Sales Ratio of 0.62, Dividend Yield of 0.0018 or Days Sales Outstanding of 1.57. Agenus financial statements analysis is a perfect complement when working with Agenus Valuation or Volatility modules.
  
Build AI portfolio with Agenus Stock
Check out the analysis of Agenus Correlation against competitors.
Evaluating Agenus's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Agenus Inc's fundamental strength.

Latest Agenus' Net Income Growth Pattern

Below is the plot of the Net Income of Agenus Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Agenus Inc financial statement analysis. It represents the amount of money remaining after all of Agenus Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Agenus' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agenus' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (232.27 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Agenus Net Income Regression Statistics

Arithmetic Mean(119,107,138)
Coefficient Of Variation(70.04)
Mean Deviation71,545,051
Median(120,692,000)
Standard Deviation83,426,577
Sample Variance6960T
Range234.4M
R-Value(0.84)
Mean Square Error2180.4T
R-Squared0.71
Significance0.000024
Slope(13,884,521)
Total Sum of Squares111359.9T

Agenus Net Income History

2026-194.3 M
2025-204.5 M
2024-227.2 M
2023-245.8 M
2022-220.1 M
2021-23.9 M
2020-180.9 M

Other Fundumenentals of Agenus Inc

Agenus Net Income component correlations

About Agenus Financial Statements

Agenus investors utilize fundamental indicators, such as Net Income, to predict how Agenus Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-209 M-198.6 M
Net Loss-209 M-198.6 M
Net Loss-198.3 M-188.3 M
Net Loss(12.17)(12.78)
Net Income Per E B T 0.88  0.53 

Pair Trading with Agenus

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agenus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will appreciate offsetting losses from the drop in the long position's value.

Moving together with Agenus Stock

  0.63OSE OSE Pharma SAPairCorr

Moving against Agenus Stock

  0.81EQ EquilliumPairCorr
  0.736C1 CytomX TherapeuticsPairCorr
  0.67DRTS Alpha Tau MedicalPairCorr
  0.63DSGN Design TherapeuticsPairCorr
  0.56GXEA Galapagos NV Earnings Call TomorrowPairCorr
The ability to find closely correlated positions to Agenus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agenus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agenus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agenus Inc to buy it.
The correlation of Agenus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agenus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agenus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agenus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:
Check out the analysis of Agenus Correlation against competitors.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Will Biotechnology sector continue expanding? Could Agenus diversify its offerings? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Agenus data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(1.57)
Revenue Per Share
3.977
Quarterly Revenue Growth
0.204
Return On Assets
(0.17)
Return On Equity
(12.79)
Investors evaluate Agenus Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Agenus' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Agenus' market price to deviate significantly from intrinsic value.
Understanding that Agenus' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Agenus represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Agenus' market price signifies the transaction level at which participants voluntarily complete trades.